Voclosporin ( DrugBank: Voclosporin )

2 diseases

ID	Disease name (Link within this page)	Number of trials
49	Systemic lupus erythematosus	1
222	Primary nephrotic syndrome	1

49. Systemic lupus erythematosus

Clinical trials : 993 / Drugs : 702 - (DrugBank : 184) / Drug target genes : 116 - Drug target pathways : 200

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05306873 (ClinicalTrials.gov)	October 28, 2022	11/3/2022	Examining Distinct Immunophenotypes to Validate and Enhance Rational Treatment in Systemic Lupus	A Phase 2, Double-Blind, Placebo-Controlled Trial of Mycophenolate Mofetil Alone or With Voclosporin ...	Systemic Lupus Erythematosus	Drug: Mycophenolate Mofetil;Drug: Placebo for Mycophenolate Mofetil;Drug: Voclosporin;Drug: Placebo ...	National Institute of Allergy and Infectious Diseases (NIAID)	NULL	Recruiting	18 Years	60 Years	All	120	Phase 2	United States

Clinical trials : 310 / Drugs : 295 - (DrugBank : 117) / Drug target genes : 63 - Drug target pathways : 194

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03598036 (ClinicalTrials.gov)	June 21, 2018	14/6/2018	Dose-Exploration Evaluating the Efficacy and Safety of Voclosporinin Subjects With Focal Segmental G ...	An Open-Label Dose-Exploration Cohort Study Evaluating the Efficacy and Safety of Voclosporinin Achi ...	Focal Segmental Glomerulosclerosis	Drug: Voclosporin	Aurinia Pharmaceuticals Inc.	NULL	Terminated	18 Years	75 Years	All	5	Phase 2	United States;Dominican Republic